IHS Chemical Week

Regions :: North America :: U.S.

Amgen to Acquire a Leading Turkish API Producer

1:13 AM MDT | May 1, 2012 | Deepti Ramesh

Amgen (Thousand Oaks, CA) says it has signed an agreement to acquire 95.6% stake in Mustafa Nevzat Pharmaceuticals (Istanbul, Turkey), a privately held pharmaceutical company, for about $700 million. Mustafa Nevzat Pharmaceuticals is one of the leading manufacturers of active pharmaceutical ingredients (APIs) and finished dosage forms in Turkey. Mustafa Nevzat Pharmaceuticals had revenues of about $200 million in 2011 and has grown on average at double-digit rates in local currency over the past five years, Amgen says. The API manufacturing complex of Mustafa...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa